Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,296.00
(
0.68%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.01
(
-0.64%
)
Bitcoin
74,032.41
(
0.12%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 127573

Monday, 11/14/2011 8:46:50 AM

Monday, November 14, 2011 8:46:50 AM

Post# of 257253

Pending presentation of the full dataset from this study

It's out:

Bayer’s Xarelto® (Rivaroxaban) Meets Primary Efficacy Endpoint and Shows Significant Reduction in Mortality in Major ACS Study

http://www.press.bayer.com/baynews/baynews.nsf/ID/1BB516127D005F31C125794700400491
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now